Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : LinearDNA SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : EvviVax
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The linDNA-LNP vaccine, designed and manufactured, will be used in upcoming in vivo animal studies to assess the performance of linDNA-LNP vaccines and will inform the final design of the company’s lead veterinary asset, a linDNA-LNP canine lymphoma va...
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Not Applicable
July 25, 2022
Lead Product(s) : LinearDNA SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : EvviVax
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?